The Latest Breaking News from Obesity

Children whose mothers are exposed to toxic PFAS can experience phenomenon previously linked to fetal tobacco smoke exposure

A cross sectional population based survey from 31 states and union territories of the country has found the prevalence of major metabolic non-communicable diseases like diabetes, hypertension, high cholesterol, obesity and prediabetes.

Ministers have announced plans which could see tens of thousands given access to new weight-loss drug

The Wegovy drug has been approved for use in the NHS already but under current plans, only a select number of people would gain access to it. The new two-year trial aims to make it available to tens of thousands more people.

Medics have outlined the common side effects and potentially damaging health risks of the new weight loss drug, known as Wegovy, available to patients on the NHS

The jab will be rolled out to thousands of people in a two year trial costing £40m

Prime Minister Rishi Sunak said the use of drugs to tackle obesity could be a ‘game-changer’ to ease pressure on the NHS

People taking a weight-loss drug can lose up to 15% of their body weight after one year, with results apparent within the first month

Prime Minister Rishi Sunak said the use of drugs to tackle obesity could be a ‘game-changer’ to ease pressure on the NHS.

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

Health experts criticise government policy failures after firefighters help move people 2,319 times in 2022